We are live on ! Find out more
DVAX

Dynavax Technologies

Delisted

DVAX was delisted on the 9th of February, 2026.

130 hedge funds and large institutions have $640M invested in Dynavax Technologies in 2016 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 60 increasing their positions, 33 reducing their positions, and 39 closing their positions.

New
Increased
Maintained
Reduced
Closed

82% more repeat investments, than reductions

Existing positions increased: 60 | Existing positions reduced: 33

67% more funds holding in top 10

Funds holding in top 10: 35 (+2)

50% more call options, than puts

Call options by funds: $20.4M | Put options by funds: $13.6M

14% less funds holding

Funds holding: 152130 (-22)

16% less capital invested

Capital invested by funds: $760M → $640M (-$120M)

51% less first-time investments, than exits

New positions opened: 19 | Existing positions closed: 39

Holders
130
Holders Change
-22
Holders Change %
-14.47%
% of All Funds
3.46%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.13%
New
19
Increased
60
Reduced
33
Closed
39
Calls
$20.4M
Puts
$13.6M
Net Calls
+$6.76M
Net Calls Change
-$19.6M
Name Holding Trade Value Shares
Change
Change in
Stake
Federated Hermes
1
Federated Hermes
Pennsylvania
$61.7M +$4.6M +227,671 +8%
Fidelity Investments
2
Fidelity Investments
Massachusetts
$43.8M -$7.24M -358,222 -14%
O
3
OrbiMed
New York
$38M -$10.1M -497,500 -20%
State Street
4
State Street
Massachusetts
$32M +$11.1M +548,310 +49%
AC
5
Amici Capital
New York
$31.5M -$4.86M -240,623 -13%
Vanguard Group
6
Vanguard Group
Pennsylvania
$28.6M +$95K +4,700 +0.3%
Bank of America
7
Bank of America
North Carolina
$28.5M +$8.87M +438,977 +42%
GA
8
Glenhill Advisors
New York
$22.5M +$13.8M +681,390 +139%
Franklin Resources
9
Franklin Resources
California
$18.8M +$3.26M +161,400 +20%
CAM
10
Cormorant Asset Management
Massachusetts
$18.8M +$8.08M +400,000 +70%
BIT
11
BlackRock Institutional Trust
California
$18.3M -$1.03M -51,010 -5%
BFA
12
BlackRock Fund Advisors
California
$18.3M -$900K -44,525 -4%
Ameriprise
13
Ameriprise
Minnesota
$16.6M +$5.32M +263,148 +44%
Point72 Asset Management
14
Point72 Asset Management
Connecticut
$15.5M +$16.3M +804,126 New
UBS AM
15
UBS AM
Illinois
$10.8M +$11M +542,627 +3,321%
BC
16
Broadfin Capital
New York
$10.5M -$1.66M -81,900 -13%
NLVP
17
New Leaf Venture Partners
New York
$9.54M -$1.03M -50,956 -9%
Northern Trust
18
Northern Trust
Illinois
$8.31M +$148K +7,336 +2%
Goldman Sachs
19
Goldman Sachs
New York
$8.29M -$1.28M -63,316 -13%
PC
20
Polar Capital
United Kingdom
$8.27M -$13.2M -650,944 -60%
CCM
21
Clovis Capital Management
New York
$8.2M +$4.26M +210,766 +98%
D.E. Shaw & Co
22
D.E. Shaw & Co
New York
$7.88M +$5.44M +268,970 +191%
CCP
23
Clough Capital Partners
Massachusetts
$7.76M +$831K +41,100 +11%
VC
24
Vivo Capital
California
$6.88M +$7.23M +357,755 New
William Blair & Company
25
William Blair & Company
Illinois
$6.16M +$2.29M +113,079 +55%

DVAX Hedge Fund Activity: Q1 2016 in Review

130 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Dynavax Technologies (DVAX) for Q1 2016, worth a combined $640M — down 16% from $760M a quarter earlier.

Sellers outnumbered buyers: 39 funds closed out of DVAX and 19 opened new positions — a net loss of 20 holders — while 33 trimmed existing stakes and 60 added.

The largest buyer was Point72 Asset Management, opening a new position worth an estimated $16.3M. The largest seller was Polar Capital, cutting an estimated $13.2M.

  • 130 institutional investors held Dynavax Technologies (DVAX) as of Q1 2016, down from 152 in Q4 2015.
  • Funds reported $640M of Dynavax Technologies stock for Q1 2016, down 16% quarter-over-quarter.
  • 19 funds opened new Dynavax Technologies positions in Q1 2016 and 39 closed out, a net change of -20 holders.
  • The largest Dynavax Technologies buyer in Q1 2016 was Point72 Asset Management, an estimated $16.3M added.
  • The largest Dynavax Technologies seller in Q1 2016 was Polar Capital, an estimated $13.2M sold.

Based on aggregated 13F filings for Q1 2016.